arXiv:2509.12777cs.CVcs.AI2025-09ICCV被引 2

用多期增强CT数据区分胰腺癌亚型,准确率超97%

CECT-Mamba: a Hierarchical Contrast-enhanced-aware Model for Pancreatic Tumor Subtyping from Multi-phase CECT

  • 设计双层级对比增强感知Mamba模块,融合多期CT时空特征
  • 在270例临床数据上实现97.4%准确率与98.6%AUC
  • 适合医学影像分析、胰腺肿瘤智能诊断方向研究者

增强型计算机断层扫描(CECT)是提供病灶时空信息的主要影像技术,有助于胰腺肿瘤的精准诊断与亚型分类。然而,胰腺肿瘤高度异质性与变异性仍给精确亚型判别带来挑战。现有方法未能有效利用放射科医生诊断流程中常见的多期CECT数据中的上下文信息,制约了性能提升。本文首次提出一种自动融合多期CECT数据以区分胰腺肿瘤亚型的方法,核心在于采用具有优异学习能力与简洁性的Mamba模型,实现对多期CECT的时空建模。具体提出双层级对比增强感知Mamba模块,引入两种新型空间与时间采样序列,以挖掘病灶内部及跨期对比度变化。同时设计相似性引导精炼模块,强化对时间变化更显著局部肿瘤区域的学习。此外,构建空间互补集成器与多粒度融合模块,编码并聚合多尺度语义信息,提升亚型分类效率。在包含270例临床病例的自建数据集上,该方法在区分胰腺导管腺癌(PDAC)与胰腺神经内分泌瘤(PNETs)任务中达到97.4%准确率与98.6% AUC,展现出更高精度与效率。

原文摘要 · Abstract (English)

Contrast-enhanced computed tomography (CECT) is the primary imaging technique that provides valuable spatial-temporal information about lesions, enabling the accurate diagnosis and subclassification of pancreatic tumors. However, the high heterogeneity and variability of pancreatic tumors still pose substantial challenges for precise subtyping diagnosis. Previous methods fail to effectively explore the contextual information across multiple CECT phases commonly used in radiologists' diagnostic workflows, thereby limiting their performance. In this paper, we introduce, for the first time, an automatic way to combine the multi-phase CECT data to discriminate between pancreatic tumor subtypes, among which the key is using Mamba with promising learnability and simplicity to encourage both temporal and spatial modeling from multi-phase CECT. Specifically, we propose a dual hierarchical contrast-enhanced-aware Mamba module incorporating two novel spatial and temporal sampling sequences to explore intra and inter-phase contrast variations of lesions. A similarity-guided refinement module is also imposed into the temporal scanning modeling to emphasize the learning on local tumor regions with more obvious temporal variations. Moreover, we design the space complementary integrator and multi-granularity fusion module to encode and aggregate the semantics across different scales, achieving more efficient learning for subtyping pancreatic tumors. The experimental results on an in-house dataset of 270 clinical cases achieve an accuracy of 97.4% and an AUC of 98.6% in distinguishing between pancreatic ductal adenocarcinoma (PDAC) and pancreatic neuroendocrine tumors (PNETs), demonstrating its potential as a more accurate and efficient tool.

胰腺肿瘤多期CTMamba图像分类

Thank you to arXiv for use of its open access interoperability. PaperDance 不是 arXiv 官方产品;中文卡片由大模型生成,请以原文为准。